Quarterly Result7 Feb 2026, 04:31 pm
Link Pharma Chem Ltd to Approve Q3 and Nine Months Results on February 14, 2026
AI Summary
Link Pharma Chem Ltd has informed the BSE that a meeting of the Board of Directors is scheduled on 14th February, 2026. The meeting will consider and approve the unaudited financial results of the Company for the quarter and nine months ended on December 31, 2025. The trading window of the Company is closed from January 1, 2026, and will open 48 hours after the declaration of the unaudited financial results.
Key Highlights
- Link Pharma Chem Ltd to consider and approve unaudited financial results for Q3 and nine months ended December 31, 2025
- Trading window closed from January 1, 2026, and will open 48 hours after the declaration of results
Price Impact
More from LINKPH